No Post Content Setup...
PositionExecutive Director
JoinedFebruary 6, 2015
Suzanne Robotti, Founder of MedShadow Foundation Inc., entered the realm of patient advocacy driven by personal health challenges. Her mother's DES exposure in the 1950s and 1960s led Robotti to engage with DES Action, and her own struggles with infertility due to DES prompted her to advocate for others. Concerns about her son's medication side effects inspired her to delve into the impact of Ritalin. In 2014, MedShadow Foundation acquired DES Action USA, expanding its advocacy for those exposed to the harmful drug diethylstilbestrol (DES).
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
No Post Content Setup...
